Article references (57 references )

  1. Verdonck K, Gonzßlez E, Van Dooren S, Vandamme A-M, Vanham G, Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis. 2007 Apr; 7(4): 266-81. PubMed | Google Scholar

  2. Shindo N, Alcantara LCJ, Van Dooren S, Salemi M, Costa MCR, Kashima S et al. Human Retroviruses (HIV and HTLV) in Brazilian Indians: seroepidemiological study and molecular epidemiology of HTLV Type 2 isolates. AIDS Res Hum Retroviruses. 2002 Jan 5; 18(1): 71-7. PubMed | Google Scholar

  3. Ticona E, Huaman MA, Yanque O, Zunt JR. HIV and HTLV-1 coinfection: the need to initiate antiretroviral therapy. J Int Assoc Provid AIDS Care. 2013 Nov-Dec; 12(6): 373-4. PubMed | Google Scholar

  4. UNAIDS. Accessed 2017 Jun 21.

  5. Nicolas D, Ambrosioni J, Paredes R, Marcos M'ngeles, Manzardo C, Moreno A et al. Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4. Expert Rev Anti Infect Ther. 2015 Aug 3; 13(8): 947-63. PubMed | Google Scholar

  6. Shahnaz S, Reich D, ArÚvalo-Valencia D, Kucinska S, Tulczynska J, Fleischman J. HTLV-1-associated adult T cell leukemia lymphoma presenting as granulomatous pneumocystis jiroveci pneumonia (PJP) and hypercalcemia. J Gen Intern Med. 2007 Mar; 22(3): 420-3. PubMed | Google Scholar

  7. Lyell V, Khatamzas E, Allain T. Severe hypercalcaemia and lymphoma in an HTLV-1 positive Jamaican woman: a case report. J Med Case Rep. 2007 Jul 25; 1: 56. PubMed | Google Scholar

  8. Edwards CMB, Edwards SJE, Bhumbra RP, Chowdhury TA. Severe refractory hypercalcaemia in HTLV-1 infection. J R Soc Med. 2003 Mar; 96(3): 126-7. PubMed | Google Scholar

  9. Naik S, Kodali S, Agheli A, Dumlao T, Singh V, Plummer K et al. HTLV-1 Adult T cell leukemia-lymphoma presenting with refractory hypercalcemia, cranial neuropathy and diagnosis by flow cytometry and cytogenetic findings. Blood. 2015; 110: 3864. Google Scholar

  10. Nasir IA, Ahmad AE, Emeribe AU, Shehu MS, Medugu JT, Babayo A. Molecular detection and clinical implications of HTLV-1 infections among antiretroviral therapy-na´ve HIV-1-infected Individuals in Abuja. Nigeria Virology (Auckl). 2015 Jan; 6: 17-23. PubMed | Google Scholar

  11. Gudo ES, Bhatt NB, Bila DR, Abreu CM, Tanuri A, Savino W et al. Co-infection by human immunodeficiency virus type 1 (HIV-1) subtype C and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS. BMC Infect Dis. 2009 Jan; 9: 211. PubMed | Google Scholar

  12. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec; 77(12): 7415-9. PubMed | Google Scholar

  13. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A. 1982 Mar; 79(6): 2031-5. PubMed | Google Scholar

  14. Gonšalves DU, Proietti FA, Ribas JGR, Ara˙jo MG, Pinheiro SR, Guedes AC et al. Epidemiology, treatment and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev. 2010 Jul; 23(3): 577-89. PubMed | Google Scholar

  15. Gessain A, Cassar O. Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol. 2012; 3: 388. PubMed | Google Scholar

  16. Mazanderani AH, Ebrahim O. Progressive HIV infection in the presence of a raised CD4+ count: HIV/HTLV-1 co-infection. South African J HIV Med. 2013; 14(2): 92-4. Google Scholar

  17. Pierik LT, Murphy EL. The clinical significance of HTLV-I and HTLV-II infection in the AIDS epidemic. AIDS Clin Rev. 1991 Jan; 39-57. PubMed | Google Scholar

  18. De Rossi A, Saggioro D, Calabrˇ ML, Cenzato R, Chieco-Bianchi L. Reciprocal activation of human T-lymphotropic viruses in HTLV-I-transformed cells superinfected with HIV-1. J Acquir Immune Defic Syndr. 1991 Jan; 4(4): 380-5. PubMed | Google Scholar

  19. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A et al. HTLV-I associated myelopathy, a new clinical entity. Lancet (London, England). 1986 May 3; 1(8488): 1031-2. PubMed | Google Scholar

  20. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet (London, England). 1985 Aug 24; 2(8452): 407-10. PubMed | Google Scholar

  21. LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet (London, England). 1990 Dec 1; 336(8727): 1345-7. PubMed | Google Scholar

  22. Ijichi S, Matsuda T, Maruyama I, Izumihara T, Kojima K, Niimura T et al. Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier. Ann Rheum Dis. 1990 Sep; 49(9): 718-21. PubMed | Google Scholar

  23. Taylor GP, Goon P, Furukawa Y, Green H, Barfield A, Mosley A et al. Zidovudine plus lamivudine in human T-lymphotropic virus type-I-associated myelopathy: a randomised trial. Retrovirology. 2006 Sep 19; 3: 63. PubMed | Google Scholar

  24. Trevino A, Parra P, Bar-Magen T, Garrido C, de Mendoza C, Soriano V. Antiviral effect of raltegravir on HTLV-1 carriers. J Antimicrob Chemother. 2012 Jan 1; 67(1): 218-21. PubMed | Google Scholar

  25. Kikuchi M, Jaffes E, Ralfkiaer E. World Health Organization Classification of Tumours. Tumours of Haemopoietic and lymphoid tissues. Jaffes E, Harris N, Stein H, Vardiman J, editors. Lyon: IARC press; 2001. pg. 200-203.

  26. Matutes E, Catovsky D. Adult T cell leukaemia lymphoma. 3rd ed Oxford: blackwell scientific publications; 1998. 416-433.

  27. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the lymphoma study group (1984-87). Br J Haematol. 1991 Nov; 79(3): 428-37. PubMed | Google Scholar

  28. Aouba A, Lambotte O, Vasiliu V, Divine M, Valensi F, Varet B et al. Hemophagocytic syndrome as a presenting sign of transformation of smoldering to acute adult T-cell leukemia/lymphoma: efficacy of anti-retroviral and interferon therapy. Am J Hematol. 2004 Jun; 76(2): 187-9. PubMed | Google Scholar

  29. Gill PS, Harrington W, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA et al. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med. 1995 Jun 29; 332(26): 1744-8. PubMed | Google Scholar

  30. Hermine O, Bouscary D, Gessain A, Turlure P, Leblond V, Franck N et al. Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med. 1995 Jun 29; 332(26): 1749-51. PubMed | Google Scholar

  31. Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan clinical oncology group study JCOG9801. J Clin Oncol. 2007 Dec 1; 25(34): 5458-64. PubMed | Google Scholar

  32. Ishida T, Jo T, Takemoto S, Suzushima H, Uozumi K, Yamamoto K et al. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. Br J Haematol. 2015 Jun; 169(5): 672-82. PubMed | Google Scholar

  33. Bessong PO, Mathomu LM. Seroprevalence of HTLV1/2, HSV1/2 and Toxoplasma gondii among chronic HIV-1 infected individuals in rural northeastern South Africa. African J Microbiol Res. 2010; 4(23): 2587-91. Google Scholar

  34. Cortes E, Detels R, Aboulafia D, Li XL, Moudgil T, Alam M et al. HIV-1, HIV-2 and HTLV-I infection in high-risk groups in Brazil. N Engl J Med. 1989 Apr 13; 320(15): 953-8. PubMed | Google Scholar

  35. Hattori T, Koito A, Takatsuki K, Ikematsu S, Matsuda J, Mori H et al. Frequent infection with human T-cell lymphotropic virus type I in patients with AIDS but not in carriers of human immunodeficiency virus type 1. J Acquir Immune Defic Syndr. 1989 Jan; 2(3): 272-6. PubMed | Google Scholar

  36. Bhigjee AI, Vinsen C, Windsor IM, Gouws E, Bill PL, Tait D. Prevalence and transmission of HTLV-I infection in Natal/KwaZulu. S Afr Med J. 1993 Sep; 83(9): 665-7. PubMed | Google Scholar

  37. van der Ryst E, Joubert G, Smith MS, Terblanche M, Mollentze F, Pretorius AM. HTLV-I infection in the Free State region of South Africa: a sero-epidemiologic study. Cent Afr J Med. 1996 Mar; 42(3): 65-8. PubMed | Google Scholar

  38. Casoli C, Pilotti E, Bertazzoni U. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression. AIDS Rev. 2007 Jul-Sep; 9(3): 140-9. PubMed | Google Scholar

  39. Cleghorn FR, Blattner WA. Does human T-cell lymphotropic virus type I and human immunodeficiency virus type 1 coinfection accelerate acquired immunodeficiency syndrome? The jury is still out. Arch Intern Med. 1992 Jul; 152(7): 1372-3. PubMed | Google Scholar

  40. Brites C, Pedroso C, Netto E, Harrington W, GalvŃo-Castro B, Couto-Fernandez J et al. Co-Infection by HTLV-I/II is Associated With Increased Viral Load in PBMC of HIV-1 Infected Patients in Bahia, Brazil. Braz J Infect Dis. 1998 Apr; 2(2): 70-7. PubMed | Google Scholar

  41. Demontis MA, Hilburn S, Taylor GP. Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases. AIDS Res Hum Retroviruses. 2013 Feb; 29(2): 359-64. PubMed | Google Scholar

  42. Pedral-Sampaio D, Martins Netto E, Pedrosa C, Brites C, Duarte M, Harrington W. Co-infection of tuberculosis and HIV/HTLV retroviruses: frequency and prognosis among patients admitted in a Brazilian hospital. Braz J Infect Dis. 1997 Mar; 1(1): 31-5. PubMed | Google Scholar

  43. Zane L, Sibon D, Mortreux F, Wattel E. Clonal expansion of HTLV-1 infected cells depends on the CD4 versus CD8 phenotype. Front Biosci (Landmark Ed. 2009 Jan 1; 14: 3935-41. PubMed | Google Scholar

  44. Bhatt NB, Gudo ES, Semß C, Bila D, Di Mattei P, Augusto O et al. Loss of correlation between HIV viral load and CD4+ T-cell counts in HIV/HTLV-1 co-infection in treatment naive Mozambican patients. Int J STD AIDS. 2009 Dec; 20(12): 863-8. PubMed | Google Scholar

  45. Ginaldi L, De Martinis M, D'Ostilio A, Di Gennaro A, Marini L, Profeta V et al. Activated naive and memory CD4+ and CD8+ subsets in different stages of HIV infection. Pathobiology. 1997 Jan; 65(2): 91-9. PubMed | Google Scholar

  46. Mukae H, Kohno S, Morikawa N, Kadota J, Matsukura S, Hara K. Increase in T-cells bearing CD25 in bronchoalveolar lavage fluid from HAM/TSP patients and HTLV-I carriers. Microbiol Immunol. 1994 Jan; 38(1): 55-62. PubMed | Google Scholar

  47. Beilke MA, Theall KP, O'Brien M, Clayton JL, Benjamin SM, Winsor EL et al. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2. Clin Infect Dis. 2004 Jul 15; 39(2): 256-63. PubMed | Google Scholar

  48. Regis C, Oliveira A, Brites C. Onset of opportunistic infections in patients co-infected by HTLV-1 and HIV-1, with high CD4+ cells count. Braz J Infect Dis. 2009 Aug; 13(4): 311-3. PubMed | Google Scholar

  49. Brites C, Sampalo J, Oliveira A. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression. AIDS Rev. 2009 Jan-Mar; 11(1): 8-16. PubMed | Google Scholar

  50. World Health Organisation. Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. 2015. Google Scholar

  51. Cullinan K. ARVs now for anyone with HIV-Motsoaledi. Johannesburg; 2016. Health24, HIV/AIDS. Accessed 2017 May 24.

  52. Nosaka K, Miyamoto T, Sakai T, Mitsuya H, Suda T, Matsuoka M. Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells. Blood. 2002 Jan 15; 99(2): 634-40. PubMed | Google Scholar

  53. Canellos GP. Hypercalcemia in malignant lymphoma and leukemia. Ann N Y Acad Sci. 1974; 230: 240-6. PubMed | Google Scholar

  54. Hagler KT, Lynch JW. Paraneoplastic manifestations of lymphoma. Clin Lymphoma. 2004 Jun; 5(1): 29-36. PubMed | Google Scholar

  55. Loh HH, Mohd Noor N. The use of hemodialysis in refractory hypercalcemia secondary to parathyroid carcinoma. Case reports Crit care. 2014 Jan; 2014: 140906. PubMed | Google Scholar

  56. Camus C, Charasse C, Jouannic-Montier I, Seguin P, Tulzo YL, Bouget J et al. Calcium free hemodialysis: experience in the treatment of 33 patients with severe hypercalcemia. Intensive Care Med. 1996 Feb; 22(2): 116-21. PubMed | Google Scholar

  57. Adhikaree J, Newby Y, Sundar S. Denosumab should be the treatment of choice for bisphosphonate refractory hypercalcaemia of malignancy. BMJ Case Rep. 2014 Jan; 2014. Google Scholar